AstraZeneca Pharma India Limited has announced that an Administrative Committee of its Board of Directors has approved the surrender of its factory license to the Department of Factories, Boilers, Industrial Safety and Health for cancellation. This license was valid up to December 31, 2026. This action is in furtherance to previous intimations regarding the exit from the manufacturing site and the surrender of the manufacturing license. The details provided indicate that the regulatory authority is the Department of Factories, Boilers, Industrial Safety and Health. The company has surrendered its factory license, which was originally valid from December 14, 2023, to December 31, 2026. The announcement states that the impact and relevance of this surrender to the listed entity, as well as any estimated monetary impact or penalties, are not applicable. Consequently, no specific corrective actions are detailed as a result of this surrender.
